Wednesday, July 8, 2026

Patent intelligence · US

US 8912172

Skin external preparation containing triterpenic acid

granted A61KA61K31/56A61K8/347A61K8/63
Status granted
Linked drugs 1
Pipeline programs 6
Years to expiry 8
Applicant portfolio 132
Patent details — US 8912172
Jurisdiction
US
Status
granted
Grant date
Dec 16, 2014
Expiration
Dec 11, 2034
Applicant
KURARAY CO., LTD.
Claims
16
CPC classes
A61K, A61K31/56, A61K8/347, A61K8/63
View on Google Patents ↗

Quick answer

US 8912172 (Skin external preparation containing triterpenic acid) is held by KURARAY CO., LTD.. Status: granted. Granted Dec 16, 2014. Expires Dec 11, 2034 (8 years remaining) — relevant for patent-cliff and LOE planning.

Key facts

Applicant
KURARAY CO., LTD.
Grant date
Expiration
Claims
16
CPC classes
A61K, A61K31/56, A61K8/347, A61K8/63, A61K9/0014, A61P

More from KURARAY CO., LTD.

Related pharmaceutical patents in our USPTO index.

  1. US 12410184

    Crystalline forms of a menin inhibitor

    Kura Oncology, Inc. · Expires Sep 4, 2045

    granted
  2. US 12377026

    Dental adhesive material kit

    KURARAY NORITAKE DENTAL INC. · Expires Jul 31, 2045

    granted
  3. US 12358210

    Resin composition for stereolithography

    KURARAY NORITAKE DENTAL INC. · Expires Jul 10, 2045

    granted
  4. US 12344691

    Resin composition for stereolithography

    KURARAY NORITAKE DENTAL INC. · Expires Jun 26, 2045

    granted
  5. US 12214061

    Adhesive composition for dental use

    KURARAY NORITAKE DENTAL INC. · Expires Jan 30, 2045

    granted
  6. US 12208148

    Dental restorative curable composition

    KURARAY NORITAKE DENTAL INC. · Expires Jan 23, 2045

    granted
  7. US 12145888

    Zirconia molded body and pre-sintered body capable of being sintered in short time

    KURARAY NORITAKE DENTAL INC. · Expires Nov 14, 2044

    granted
  8. US 12138325

    Dental composition

    KURARAY NORITAKE DENTAL INC. · Expires Nov 7, 2044

    granted

Frequently asked questions

What is US patent 8912172?

US 8912172 (Skin external preparation containing triterpenic acid) is held by KURARAY CO., LTD.. Status: granted. Granted Dec 16, 2014. Expires Dec 11, 2034 (8 years remaining) — relevant for patent-cliff and LOE planning.

Who owns US 8912172?

KURARAY CO., LTD. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 132 pharmaceutical patents for this assignee.

When does US 8912172 expire?

Our index shows an expiration date of Dec 11, 2034 (8 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.